Gupta A, Mahalakshmi R. Helix-strand interaction regulates stability and aggregation of the human mitochondrial membrane protein channel VDAC3.
J Gen Physiol 2019;
151:489-504. [PMID:
30674561 PMCID:
PMC6445588 DOI:
10.1085/jgp.201812272]
[Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2018] [Accepted: 01/02/2019] [Indexed: 11/25/2022] Open
Abstract
Human mitochondrial VDACs bind amyloidogenic proteins, but do not intrinsically aggregate. Gupta and Mahalakshmi find that an interaction between the N-terminal α-helix and strands β7–β9 regulates VDAC aggregation and stability, providing a plausible mechanism for VDAC coaggregation in cells.
Voltage-dependent anion channels (VDACs) are β-sheet–rich transmembrane β-barrels that are vital for metabolite transport across the mitochondrial membrane. Under cellular stress, human VDACs hetero-oligomerize and coaggregate with proteins that can form amyloidogenic and neurodegenerative deposits, implicating a role for VDACs in proteotoxicity. However, whether VDACs possess intrinsic interaction sites that can lead to protein aggregation is not known. Here, we couple a systematic thiol replacement strategy with far-UV circular dichroism spectropolarimetry and UV scattering spectroscopy to map aggregation-prone regions of human VDACs, using isoform 3 as our model VDAC. We show that the region comprising strands β7–β9 is highly aggregation prone. Further, we find that an α1–β7–β9 interaction (involving the hVDAC3 N-terminal α1 helix) can lower protein aggregation, whereas perturbations of this interaction promote VDAC aggregation. We also show that hVDAC3 aggregation proceeds via a partially unfolded structure. Our findings allow us to propose a plausible mechanism for the role of human VDACs in forming proteotoxic aggregates in the cell. The key target sites on VDACs—strands β7–β9—may be useful for developing VDAC aggregation inhibitors.
Collapse